Health, Fitness & Food

Dr. Anthony Fauci speaks about the Omicron coronavirus variant during a press briefing at the White House in Washington, December 1, 2021. Kevin Lamarque | Reuters Omicron’s more contagious subvariant, BA.2, has more than doubled in prevalence over the past two weeks in the U.S. and now represents more than 34% of Covid-19 infections that
0 Comments
In this article ONEM HIMS Ambar Bhattacharyya, managing director at Maverick Ventures Maverick Ventures Ambar Bhattacharyya is managing director at Maverick Ventures, a $400 million venture capital fund based in San Francisco which invests in health start-ups. His health-care portfolio firms include six IPOs and four unicorns (start-ups valued at $1 billion or more). Bhattacharyya
0 Comments
Moderna CEO Stephane Bancel Steven Ferdman | Getty Images Moderna CEO Stephane Bancel has sold $408 million in company stock since the beginning of the pandemic — averaging roughly $3.6 million a week — as the company’s stock soared on the development and rollout of its Covid vaccine, according to CNBC’s analysis of the company’s
0 Comments
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The White House on Tuesday warned that the U.S. won’t have enough booster shots and life-saving Covid treatments for Americans
0 Comments
Low levels of natural immunity are complicating China’s efforts to limit spread during its recent surge in cases of the new Covid omicron BA.2 subvariant, Dr. Scott Gottlieb told CNBC on Monday. “China has a population that’s very vulnerable to this new variant. This is a much more contagious variant, it’s going to be harder
0 Comments